The standard management approach for these patients involved discontinuation of GLP-1 RAs and supportive care, including intravenous fluids and pain management
HMB45 antibodies are specifically targeted at melanosomes and are currently used mainly to identify melanoma [10]
The most common side effects are mild, including nausea, vomiting, bloating, constipation and diarrhea
64 Enzymatic degradation of ECM components (e.g., hyaluronidase) or blockade of ECMintegrin interactions (e.g., FAK inhibitors) can also improve drug penetration and reduce stemness-supportive niches
Realistic expectation: energy improvements may appear in 36 weeks
Unlike some weight loss methods that may yield temporary results, semaglutide has shown promising outcomes in helping individuals maintain their weight loss over an extended period